Geneyx Genomex Ltd. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Geneyx Genomex Ltd. is a Delaware-based genomics company founded in 2018. It specializes in next-generation sequencing (NGS) data analysis and clinical genetic interpretation. With a mission to integrate genomics into healthcare and pharmaceutical research, it has a global presence, operating in 190 hospitals and labs across 50 countries and analyzing over 520,000 samples.

The company offers advanced technologies such as HiFi long-read sequencing and Sequencing by Binding (SBB™) short-read technology. Its primary product, Geneyx Analysis, is a leading platform for NGS interpretation, used for secondary and tertiary analysis of exome and whole genome sequencing. In addition to clinical interpretation services and pharmacogenomics insights, their unique Phenotyper® technology enhances diagnostic yields. The platform supports human genetics, oncology, and microbiology applications, serving hospitals, life-science companies, and pharmaceutical research organizations. Geneyx has been recognized as one of the World's Best Digital Health Companies for 2024.